Drug intelligence / Profile preview

11C-sarcosine

Development stage
Preclinical
Lead developer
University of Michigan
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

11C-sarcosine is a novel radiotracer developed for PET imaging of prostate cancer. It is a radiolabeled version of sarcosine (N-methylglycine), where carbon-11 (11C) is incorporated into the molecule. 11C-sarcosine functions as a substrate for proton-coupled amino acid transporters (PATs) and has demonstrated superior tumor-to-background ratios compared to 11C-choline in prostate cancer imaging. The compound shows specific uptake in prostate cancer cells through PAT-mediated transport, which can be competitively inhibited by 5-hydroxy-l-tryptophan but not by 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid. 11C-sarcosine has favorable radiation dosimetry characteristics and has shown promising results in initial human testing for localized clinically significant prostate cancer detection.

Other names
Sarcosine C-11
02

Targets

SLC26A6 (Perilipin-5)

Beyond the preview

Go deeper on 11C-sarcosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 11C-sarcosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call